Patents Assigned to Mira Pharma Corporation
  • Injectable long-acting semi-solid gel formulations
    Patent number: 11426418
    Abstract: What is disclosed is a controlled release pharmaceutical composition comprising a biocompatible and bioerodible semi-solid gel comprising a mixture of a triglyceride of ricinoleic acid and a gelling agent, in a formulation with loteprednol, latanoprost, celecoxib, triamcinolone, or betamethasone and, optionally, a second corticosteroid, analgesic, or anti-inflammatory agent.
    Type: Grant
    Filed: February 17, 2020
    Date of Patent: August 30, 2022
    Assignee: MIRA PHARMA CORPORATION
    Inventors: Hui Rong Shen, Na Gan
  • Injectable long-acting local anesthetic semi-solid gel formulations
    Patent number: 10561606
    Abstract: What is disclosed is a controlled release pharmaceutical composition comprising a biocompatible and bioerodible semi-solid gel comprising a triglyceride of ricinoleic acid, a gelling agent, bupivacaine and, optionally, a corticosteroid, an analgesic, or an anti-inflammatory agent.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: February 18, 2020
    Assignee: Mira Pharma Corporation
    Inventors: Hui Rong Shen, Na Gan
  • Injectable long-acting local anesthetic semi-solid formulations and its compositions
    Patent number: 10500281
    Abstract: What is disclosed is a semi-solid controlled release pharmaceutical composition containing biocompatible and bioerodible semi-solid lipid matrix incorporating local anesthetics agents to form a semi-solid solution, a method of using the pharmaceutical composition to treat, and a method of making the pharmaceutical composition.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: December 10, 2019
    Assignee: Mira Pharma Corporation
    Inventors: Hui Rong Shen, Na Gan
  • Long-acting semi-solid lipid formulations
    Patent number: 10220093
    Abstract: What is described is a semi-solid controlled release composition comprising a semi-solid lipid and bupivacaine in a solution or a homogenous suspension, methods of using the composition for treating a disease, and methods of manufacturing the composition.
    Type: Grant
    Filed: December 6, 2017
    Date of Patent: March 5, 2019
    Assignee: Mira Pharma Corporation
    Inventors: Hui Rong Shen, Na Gan